Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders.
about
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaEpstein-Barr Virus: Diseases Linked to Infection and TransformationNasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentationMeta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformationDiagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for fiePurified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.Viral response to chemotherapy in endemic burkitt lymphomaCross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and RasConserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinomaSeroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.Ostreid herpesvirus type 1 replication and host response in adult Pacific oysters, Crassostrea gigas.Interleukin-4 and interferon- γ levels in Epstein-Barr virus-associated infectious mononucleosis and nasopharyngeal carcinomaEBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines.Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis.Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study.Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study.Epitope mapping of gp350/220 conserved domain of epstein barr virus to develop nasopharyngeal carcinoma (npc) vaccine.Evidence of an oncogenic gammaherpesvirus in domestic dogs.Significance of Epstein-Barr virus (EBV) load and interleukin-10 in post-transplant lymphoproliferative disorders.Gammaherpesvirus Infection of Human Neuronal Cells.Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptorsVariable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma.Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.Immune surveillance and lymphoid malignancy in immunocompromised host.Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE.Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A.Epstein-Barr Virus-Associated Acute Liver Failure Present in a 67-Year-Old Immunocompetent Female.Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein.Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay.Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises.Epstein-Barr virus and its association with Fascin expression in colorectal cancers in the Syrian population: A tissue microarray study.
P2860
Q27016002-8C7E6C62-B417-4100-BEE1-2109D37D5F9BQ28074586-80C6AE0C-DE3E-400B-850D-E22E09D54CB2Q28680671-DD5BAF1C-7162-4B6F-BDC6-37DE093FB040Q30844939-6AD53B75-C969-4B62-88AA-55700C769145Q33218405-835A7ACB-23BA-4521-ACAB-4799D6A4FF23Q33239049-E214E9D2-1FBC-41CE-87AE-482D73544662Q33760249-7799E7C0-4090-4BDC-B820-32C8DF485624Q33767066-B54837EA-FF78-4F98-A84E-FAD27CA8F4B2Q34162351-634204D8-D5FA-4BBB-AFA3-982BE6F1EE07Q34173615-54610C38-4BF4-4AB9-A6BC-742104F1602FQ34202451-CFA9518C-7EDC-49AF-89AB-E5B71C05FFF8Q34346271-B14810CE-BC97-4456-A23D-998AF26F3D9CQ34714027-2BAB8B7F-E598-4AFD-9FDE-D135A947B053Q35040644-6F8A9DE4-51E1-4CC5-8B0E-0ECBA03B88D4Q35171856-104C74F2-4E7A-4E38-B317-EF1B3225A936Q35587610-02BE6203-5D5B-4C66-8D8E-E14BE3016F8EQ35599997-4111A816-69F5-4EBA-927F-67EEF66AF337Q35887107-4C405A2E-08F4-4060-8B1A-FCC493069B6AQ36029129-3A310DC8-ADE7-4BE5-A925-BD6D0338D377Q36119183-CE5C9B20-ABCC-4E5E-B616-3139BDE92CA6Q36272592-DA288EC7-1DA5-40CD-897B-EFFF94ECFBFCQ36346036-E3B22279-4B46-4AEE-88C1-1D58870230E7Q36497002-90D48A2B-334B-4D1B-B178-14465B24081EQ36537637-34D52B81-B4B7-44FE-B98C-0EF7C0690B92Q36713194-F6089047-AAC3-4D73-AEEA-9DADD6796BA9Q36747951-70159BF7-F9F2-43AF-B50A-A04D54F99C57Q36831205-867FC49C-0FE4-4FB7-8FF3-D206D79139E1Q36978556-09D9A60B-7963-4778-8497-F1527A17F04AQ37097402-C02A75A4-44EE-4417-B1C0-184DE738977CQ37292932-28FEC074-9259-4047-9F77-E7BB5C445D58Q37330822-BDE2F771-8569-4C56-8EAF-D8B7999884D2Q37410691-59AA2B13-42F3-471B-ADAD-DB633C044882Q37456672-5E516FEF-144F-41F4-865B-3AEBA388F854Q37730638-2A4D3427-800B-4EC1-8F48-DA077019DEE3Q37849461-8156C218-0EA9-4AE9-830B-AF919CA73419Q37938966-280065D8-136D-4024-9C3F-0DF5902690A2Q38133428-358EE196-261E-4300-836F-1CE552396E6EQ38366750-C52849A6-7AA5-413E-9A26-F974819AD910Q38692795-D20D80FD-92AE-49E4-BC62-4A8066D8D88CQ38738531-A8CD3A89-978A-479D-893C-A1B5B336D4FC
P2860
Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@ast
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@en
type
label
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@ast
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@en
prefLabel
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@ast
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@en
P2093
P1476
Pathogenic roles for Epstein-B ...... iated proliferative disorders.
@en
P2093
Adriaan J C van den Brule
Antoinette A T P Brink
Chris J L M Meijer
Jaap M Middeldorp
P356
10.1016/S1040-8428(02)00078-1
P577
2003-01-01T00:00:00Z